Global EditionASIA 中文双语Français
China
Home / China / Top News

Beijing prepare to expand vaccine delivery

By DU JUAN | chinadaily.com.cn | Updated: 2021-03-05 19:07
Share
Share - WeChat
People wait in line at a COVID-19 vaccination site in Daxing District of Beijing, Feb 21, 2021. [Photo/Xinhua]

Beijing will provide novel coronavirus vaccinations for people over age 60 and patients with chronic diseases after enough data are collected, an expert said recently. 

Pang Xinghuo, deputy head of the Beijing Center for Disease Control and Prevention, said data on people's vaccinations and related research has been accumulating. Once the health authority gets enough data to ensure safety, the city government will start vaccinating the older people, patients with chronic diseases and people with allergies. 

Meanwhile, she said, the protection period of the novel coronavirus vaccines are not necessarily only half a year, which is widely believed by the public. 

"The reason why people say the effectiveness period is half a year is that we only have data for six months. At present, various departments are collecting data on the vaccinated population, which will give more information about the protection period of the vaccine."

A staff member checks the packages of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd, in Beijing, Dec 25, 2020. [Photo/Xinhua]

She also reminded the public that people should provide detailed and accurate information about their health condition, especially any history of allergies, to doctors before receiving their vaccination.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US